HCA Healthcare, Inc.
HCA · NYSE
Company research
HCA Healthcare, Inc. (NYSE: HCA) is the largest for-profit hospital operator in the United States, founded in 1968 and headquartered in Nashville, Tennessee, under the leadership of CEO Samuel N. Hazen. The company operates an extensive network of approximately 190 hospitals and 2,500+ sites of care — including freestanding ambulatory surgery centers, emergency care facilities, urgent care clinics, diagnostic and imaging centers, and psychiatric hospitals — across 19 U.S. states (with a heavy concentration in Florida and Texas) and the United Kingdom. With roughly 320,000 full-time employees and revenues exceeding $70 billion as of 2024, HCA delivers a full continuum of healthcare services spanning inpatient acute care, outpatient surgery, behavioral health, rehabilitation, and emergency medicine. The company's competitive strategy centers on building dense, integrated local care networks in high-growth urban and suburban markets, leveraging its massive scale to drive cost efficiencies while investing in technology, AI-driven clinical workflows, and proprietary workforce development programs to strengthen its market-leading position.
Research reports
Investing.com · May 23, 2026HCA Healthcare’s SWOT analysis: stock gains momentum on guidance
This article presents a structured SWOT analysis of HCA following updated guidance, highlighting strengths such as scale, resilient revenue growth and solid profitability while noting weaknesses around leverage and exposure to reimbursement and labor-cost pressures. It emphasizes opportunities from demographic tailwinds and outpatient expansion, and flags regulatory and cost risks, while framing the stock’s recent price momentum and guidance as supportive of a constructive, but risk-aware, outlook.
Ultra Stock Analysis Pro · April 24, 2026HCA Healthcare, Inc. (HCA) – ANALYST REPORTThis comprehensive quant-driven report assigns HCA a HOLD rating with a 6–12 month horizon, citing a current price around 432.52 versus an analyst consensus target of 542.67 (+25.5% upside) and backtested win rate and profit factor that support moderate risk-adjusted return potential. It combines detailed technical and fundamental metrics, notes oversold technical conditions, high institutional ownership and solid earnings growth, but recommends waiting for stronger signal confluence before entry due to volatility, market beta, and company- and policy-specific risks outlined in its risk assessment section.
Business Quant · April 14, 2026HCA Healthcare, Inc. (HCA) Stock Analysis and MetricsBusiness Quant’s HCA page provides a data-rich investment thesis with explicit bull and bear cases, focusing on robust 2025 revenue growth, 20%+ adjusted EBITDA margins, a large planned 2026 capital spending program, and AI-driven revenue-cycle and capacity-management initiatives as key drivers of earnings and operational efficiency. The bear case discusses material risks from health insurance exchange reforms, anticipated declines in Medicaid supplemental payments, rising physician labor costs, leverage and capital-spending exposure, and soft outpatient surgical volumes, resulting in a balanced, risk-aware view without a single explicit recommendation, hence an overall uncertain outlook.